Core Technology

ENERGI-F708  (Asthma Relief Treatment)

There are over 300 million asthma patients worldwide now, which is predicted to top 1 billion by 2025, due to increased sensitivity of atopic diathesis and the increase of allergic diseases. According o the research model using chicken egg white to induce allergic reaction of small mouse's respiratory tract and cause asthma, conducted by the National Laboratory Animal Center, under the commission of Energenesis Biomedical, F708 is proven to be effective in lowering the index of asthma inflammation and thereby improving lung inflammation.